Of the study cohort, 92% had type 2 diabetes and 86% had obesity
ABSTRACT: Glucagon-like peptide-1 (GLP-1) receptor agonists are an increasingly popular class of glucose-lowering agents for the treatment of type 2 diabetes (T2DM), owing to their robust glucose-lowering effects, low risk of hypoglycemia, and potential to induce weight loss
Wellmedrs medical weight-loss programs use advanced GLP-1 and GIP medications like Tirzepatide and Semaglutide, designed to regulate appetite, improve metabolism, and support sustainable resultsall without nausea or burnout
Feed Your Gut Fiber-rich Carbohydrates Your gut health plays a critical role in GLP-1 secretion, especially in the colon, where fermentation of undigested carbohydrates produces substances called short-chain fatty acids (SCFAs), like butyrate, propionate and acetate